Randomized Controlled Trial (RCT) of Open Debridement Versus Percutaneous Ultrasonic Treatment for Symptomatic Lateral Epicondylitis.

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Lateral epicondylitis (Tennis Elbow) can cause pain and keep individuals from completing their daily activities and require them to miss work. There are currently different treatment options to address tennis elbow. However surgeons do not know if one is better than the other. This study will compare two treatment options for tennis elbow. Participants will either be treated by Ultrasound-guided Percutaneous Tenotomy Technique or Open Surgical Debridement. Traditional open surgical debridement is a surgical procedure that requires the surgeon to make an incision to remove the damaged tissue. This procedure is done under anesthesia in a surgery center. In the Tenex procedure, the surgeon inserts a special needle into the damaged portion of the tendon under ultrasound guidance. Ultrasonic energy vibrates the damaged tissue and it can be suctioned out. This procedure is done with local anesthesia in surgeon's office.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 70
Healthy Volunteers: t
View:

• Individuals 18-70 years of age

• Clinically documented chronic lateral epicondylitis with a minimum of 6 months of persistent elbow pain that impedes daily activities.

• Failed alternative treatment for \> 3 months.

Locations
United States
New Jersey
Virtua Health Inc
RECRUITING
Burlington
Virtua Health and Wellness
RECRUITING
Cherry Hill
Virtua Cadiac Testing Center
RECRUITING
Moorestown
Virtua Hand Surgery
RECRUITING
Riverside Park
Summit Surgical Center LLC
RECRUITING
Voorhees Township
Contact Information
Primary
Donna Hoopes
dhoopes@virtua.org
856-355-1206
Time Frame
Start Date: 2023-02-09
Estimated Completion Date: 2026-06
Participants
Target number of participants: 90
Related Therapeutic Areas
Sponsors
Collaborators: Dr. Christopher Chung, Dr. Nathan Bodin, Dr. Raymond Ragland, Dr. Sean Mcmillan, Dr. Thomas Plut
Leads: Virtua Health, Inc.

This content was sourced from clinicaltrials.gov